MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status. (Q36081688)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status. |
scientific article |
Statements
MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status (English)
G W Stamp
N Lalani
C P McFarlane
1 October 1995
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference